Publications
Emily Leung, Nicholas R Fragola, Elliott W Sharp, Rebecca A Harrison, Erica Peterson, Julia Varghese, Shannon Jackson, Xiaotian Julie You, Elysha VanderVeer, Mark Trinder, Ashley Sutherland, Jan Dutz, Piotr Kaniewski, Kenneth L McClain, Oussama Abla, David C Fajgenbaum, Luke Y C Chen Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study , American Journal of Hematology.: 2026 (online ahead of print)
Marcello DeLuca, Nico Matentzoglu, Elliott Sharp, Jane Li, Charlie Hempstead, May Lim, Piotr Kaniewski, E. Kathleen Carter, Kushal Koirala, Elvin Ding, Laurens Vijnck, Pascal Brokmeier, Sabrina Toro, Kevin Schaper, Jacques Vergine, Olivia Li, Tudor I. Oprea, David C. Fajgenbaum, Christopher Bizon, Melissa Haendel, Alexander Tropsha. Medicines, Diseases, Indications, and Contraindications (MeDIC): a foundational resource to support drug repurposing , Nucleic Acids Research., 54(D1): 2026,D1477-D1487
Dorottya Laczko, Vinodh Pillai, Dale Frank, Joshua D Brandstadter, David C Fajgenbaum How I diagnose Castleman disease , American Journal of Clinical Pathology., 165(3): 2026
Elliott W Sharp, Nicholas Fragola, Charlotte Blewitt, Matthew Goddeeris, Lee Lancashire, Charlie Hempstead, David C Fajgenbaum Quantify unmet medical need across the disease landscape - A large language model-based methodology , PLOS Medicine., 23(3): 2026
Asami Nishikori, Midori Filiz Nishimura, Yoshito Nishimura, Rio Yamada, Tomoka Haratake, Daisuke Ennishi, Ryota Chijimatsu, Toshihiro Ito, Tomohiro Koga, Sayaka Ochi, Yuri Kawahara, Himawari Ueta, Yudai Takeda, Michael V. Gonzalez, David C. Fajgenbaum, Frits Van Rhee, Shuji Momose, Yasuharu Sato. Distinct interleukin-6 production in IPL and TAFRO subtypes of idiopathic multicentric Castleman disease , Haematologica.: 2025 (online ahead of print)
Mizuna Otsuka, Tomohiro Koga, Remi Sumiyoshi, Shoichi Fukui, Yuko Kaneko, Takayuki Shimizu, Atsushi Katsube, Shingo Yano, Yasufumi Masaki, Makoto Ide, Hajime Yoshifuji, Masayasu Kitano, Yasuharu Sato, Naoki Sawa, Hiroaki Niiro, Naoya Nakamura, David C. Fajgenbaum, Frits van Rhee, Atsushi Kawakami Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution Patterns , American Journal of Hematology. : 2025 (online ahead of print)
Sheila K. Pierson, Joshua D. Brandstadter, Drew Torigian, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Corey Casper, Amy Chadburn, Shanmuganathan Chandrakasan, Angela Dispenzieri, Alexander Fossa, Christian Hoffmann, Makoto Ide, Razelle Kurzrock, Sudipto Mukherjee, Sunita D. Nasta, José-Tomás Navarro, Ariela Noy, Eric Oksenhendler, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Matthew J. Streetly, Raymond Siu Ming Wong, Lu Zhang, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum Characterizing the heterogeneity of Castleman disease and oligocentric subtype: Findings from the ACCELERATE registry , Blood Advances.: 2025 (online ahead of print)
Dorottya Laczko, Patricia Tsao, Ruth-Anne Pai, Joseph Zinski, Michael V. Gonzalez, Melanie D. Mumau, Tobias Raabe, Hiromi Muramatsu, Norbert Pardi, Taku Kambayashi, David C. Fajgenbaum. A patient-derived CABIN1 mutation recapitulates features of idiopathic multicentric Castleman disease in a mouse model , Blood Advances., 9(24): 2025,6534-6537
Steven Rowe, Mariam Goubran, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Bridget Austin, Kathleen McNicholas, Marley Blommers, Junyan Shi, Lisa K. Peterson, Lusia Sepiashvili, Andre Mattman, Joshua D. Brandstadter, David C. Fajgenbaum, Luke Y. C. Chen. Ferritin, C-Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLH , American Journal of Hematology., 100(12): 2025,2421-2425
Midori Filiz Nishimura, Tomoka Haratake, Yoshito Nishimura, Asami Nishikori, Remi Sumiyoshi, Hideki Ujiie, Yuri Kawahara, Tomohiro Koga, Masao Ueki, Dorottya Laczko, Eric Oksenhendler, David C. Fajgenbaum, Frits van Rhee, Atsushi Kawakami, Yasuharu Sato. International Consensus Histopathological Criteria for Subtyping Idiopathic Multicentric Castleman Disease Based on Machine Learning Analysis , American Journal of Hematology., 100(9): 2025,1502-1512
